Maris J M, Kyemba S M, Rebbeck T R, White P S, Sulman E P, Jensen S J, Allen C, Biegel J A, Yanofsky R A, Feldman G L, Brodeur G M
Division of Oncology, The Children's Hospital of Philadelphia, Pennsylvania 19106, USA.
Cancer Res. 1996 Aug 1;56(15):3421-5.
Familial predisposition to neuroblastoma, a common embryonal cancer of childhood, segregates as an autosomal dominant trait with high penetrance. It is therefore likely that neuroblastoma susceptibility is due to germ line mutations in a tumor suppressor gene. Cytogenetic, functional, and molecular studies have implicated chromosome band 1p36 as the most likely region to contain a suppressor gene involved in sporadic neuroblastoma tumorigenesis. We now demonstrate that neuroblastoma predisposition does not map to any of eight polymorphic markers spanning 1p36 by linkage analysis in three families. In addition, there is no loss of heterozygosity at any of these markers in tumors from affected members of these kindreds. Furthermore, there is strong evidence against linkage to two Hirschsprung disease (a condition that can cosegregate with neuroblastoma) susceptibility genes, RET and EDNRB. We conclude that the neuroblastoma susceptibility gene is distinct from the 1p36 tumor suppressor and the currently identified Hirschsprung disease susceptibility genes.
神经母细胞瘤是儿童常见的胚胎性癌症,家族性神经母细胞瘤易感性作为一种具有高外显率的常染色体显性性状进行分离。因此,神经母细胞瘤易感性很可能是由于肿瘤抑制基因中的种系突变所致。细胞遗传学、功能和分子研究表明,染色体带1p36是最有可能包含与散发性神经母细胞瘤肿瘤发生相关的抑制基因的区域。我们现在通过对三个家族的连锁分析证明,神经母细胞瘤易感性并不定位于跨越1p36的八个多态性标记中的任何一个。此外,这些家族中受影响成员的肿瘤中,这些标记中的任何一个都没有杂合性缺失。此外,有强有力的证据表明,与两个先天性巨结肠病(一种可与神经母细胞瘤共分离的疾病)易感基因RET和EDNRB不存在连锁关系。我们得出结论,神经母细胞瘤易感基因与1p36肿瘤抑制基因以及目前已鉴定的先天性巨结肠病易感基因不同。